Update from Nice13 Aug 2025 15:49
Hi All
I've had the following update from NICE and people's suspicions around the lack of news in the trading update on Monday on CYP2C19 roll out are unfortunately true:
NHSE have just this week provided NICE with the following update regarding the national commissioning decision for CYP2C19 testing:
'We are aware that a number of services are keen to understand national timelines for commissioning decisions regarding further rollout of CYP2C19 testing via NHS Genomic Medicine Service laboratories, prior to the use of clopidogrel following stroke in line with NICE guidance DG59.
NHS England confirmed that information from the pilot has informed the implementation of routine commissioning and setting out an approach to national testing for the future remains a priority. However, within the current financial year, it has not been possible to identify the necessary recurrent headroom in revenue budgets to support the funding of this testing for the indicated population.
This position is being kept under active review and takes into account the need to maintain all existing services for patients across the specialised commissioning portfolio, such as the delivery of all other routinely delivered genomic tests by the NHS Genomic Medicine Service.
We will follow up with relevant outcomes from the pilot and we will continue to keep our stakeholders informed as national work progresses'.
(the below is the NICE person speaking)
I believe the implementation guidance for clopidogrel use being developed by the CERSI will still progress and publish as will an implementation guide/pilot information document. So we are hoping there will be a repository of tools for those who may wish to implement sooner. I still dont have a publication date but I am hoping for mid-late September.
I am meeting with the NHSE team in mid September to update wording on the NICE website and hope at that point to have an update re publication of the CERSI guidance and implementation guide.